Home Cart Sign in  
Chemical Structure| 2260791-14-6 Chemical Structure| 2260791-14-6

Structure of OSMI-4
CAS No.: 2260791-14-6

Chemical Structure| 2260791-14-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

OSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor with an EC50 of 3 μM in cells.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of OSMI-4

CAS No. :2260791-14-6
Formula : C27H26ClN3O7S2
M.W : 604.09
SMILES Code : COC1=C(C=CC=C1)[C@H](C(N(CC2=CC=CS2)CC(OCC)=O)=O)NS(C3=C(Cl)C=C4NC(C=CC4=C3)=O)(=O)=O
MDL No. :MFCD31813742

Safety of OSMI-4

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
GBM cells 30 μg/mL 4 hours To evaluate the cytotoxicity of nanoparticles on GBM cells, it was found that OSMI-4 significantly enhanced the cytotoxic effects of TMZ on GBM cells. PMC11583667
LeCo-2920vi 20 µM 5 days OSMI-4 in combination with 25 nM SN38 significantly enhanced cell death in LeCo-2920vi tumor organoids, validating the potential of OSMI-4 to enhance chemotherapy cytotoxicity. PMC11490504
HCT116 5-20 µM 72 hours OSMI-4 alone induced a cell cycle arrest, but when used in conjunction with a low dose of SN38, OSMI-4 resulted in a dose-dependent decrease in O-GlcNAcylation levels and SA-β-galactosidase activity compared to cells treated with SN38 alone. This combination also led to a dose-dependent increase in γH2AX, cleaved caspase 7, and cleaved PARP-1 expression, as well as a dose-dependent decrease in cell viability. PMC11490504
HEK293 10–80 µM 96 hours To evaluate the effect of OSMI-4 on cellular metabolic activity, results showed that OSMI-4b reduced global O-GlcNAcylation levels in all cell lines. PMC7436030
HEK293T 10–80 µM 96 hours To evaluate the effect of OSMI-4 on cellular metabolic activity, results showed that OSMI-4b reduced global O-GlcNAcylation levels in all cell lines. PMC7436030
K562 10–80 µM 96 hours To evaluate the effect of OSMI-4 on cellular metabolic activity, results showed that OSMI-4b reduced global O-GlcNAcylation levels in all cell lines. PMC7436030

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.66mL

0.33mL

0.17mL

8.28mL

1.66mL

0.83mL

16.55mL

3.31mL

1.66mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories